Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2002

View Archived Issues

Paxil approved in Canada for posttraumatic stress disorder

Zycos and Pharmexa sign cancer vaccine formulation agreement

Tachykinin NK1 antagonists identified at Merck

New factor Xa inhibitors patented by Sankyo

Novel antifungal agents in the BMS pipeline

Agents with dual AChE-inhibitory/antioxidant activity for use in AD

Bayer describes IkappaB kinase inhibitors as potential antiasthmatic agents

Chemokine receptor modulators claimed by AnorMED

Update on status of T-614, a new antiarthritic drug

JT to advance three products to phase III by March 2004

Novel adenoviral vector efficiently delivers E1A to tumor cells and reduces tumorigenic capacity

Locally administered AS ODN targeting a common cytokine receptor subunit for asthma

Diabetic fruit flies may provide new information on the development of human pancreatic beta-cells

Synergistic effects of the CCR5 antagonist SCH-C combined with other antiretroviral drugs

Crosslinking of thymosin beta4 to fibrin may underlie wound healing

Rho kinase as a potential target for erectile dysfunction Rx

Corixa to request appeal to FDA stance on Bexxar

Novel treatments for male erectile dysfunction

BioMarin initiates preclinical studies of NeuroTrans brain delivery technology

Mimotopes and Baker Medical Research Institute to develop novel cardiovascular drugs

RSV antibody production in greenhouse plant lines

Antistaphylococcal monoclonal antibody provides encouraging phase I results

BTG acquires HIV treatment technology from BioClonetics

ATL-104 safe and well tolerated in phase Ib trial

CeNeS updates progress of key pain products

T-20 provides positive 24-week results in second phase III HIV study

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...